These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9648714)

  • 21. Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment.
    Grunebaum E; Levy Y; Shoenfeld Y
    Isr Med Assoc J; 2002 Apr; 4(4):288-9. PubMed ID: 12001706
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunoglobulin therapy: methods of delivery.
    Ballow M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
    [No Abstract]   [Full Text] [Related]  

  • 23. 11q terminal deletion disorder and common variable immunodeficiency.
    Puglisi G; Netravali MA; MacGinnitie AJ; Bonagura VR
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):267-8. PubMed ID: 19788026
    [No Abstract]   [Full Text] [Related]  

  • 24. [Allergy and allergic diseases in children].
    Vaniukov NV
    Vopr Okhr Materin Det; 1978 Mar; 23(3):11-5. PubMed ID: 644945
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
    Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
    Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of suspected immune deficiency by the primary care physician.
    Infante AJ; Kamani NR
    Compr Ther; 1997 Feb; 23(2):89-94. PubMed ID: 9083718
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problems in the use of intravenously administered immunoglobulin].
    Martin TD
    Ter Arkh; 1996; 68(10):83-8. PubMed ID: 9026956
    [No Abstract]   [Full Text] [Related]  

  • 28. [The use of intravenous 7S immunoglobulins at high doses in HIV-related immunological pathology].
    Fiori GP
    Clin Ter; 1994 Apr; 144(4):301-5. PubMed ID: 8205754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary immunodeficiency: complex genetic disorders?
    Schejbel L; Garred P
    Clin Chem; 2007 Feb; 53(2):159-60. PubMed ID: 17259244
    [No Abstract]   [Full Text] [Related]  

  • 30. Polyclonal immunoglobulins for intravenous use induce interleukin 10 release in vivo and in vitro.
    Lories RJ; Casteels-Van Daele M; Ceuppens JL; Van Gool SW
    Ann Rheum Dis; 2004 Jun; 63(6):747-8. PubMed ID: 15140788
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunodeficiency and infections in ataxia-telangiectasia.
    Nowak-Wegrzyn A; Crawford TO; Winkelstein JA; Carson KA; Lederman HM
    J Pediatr; 2004 Apr; 144(4):505-11. PubMed ID: 15069401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous administration of IgG.
    Berger M
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):779-802, viii. PubMed ID: 18940574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of patients with primary antibody deficiencies in Germany].
    Borte M; Oertelt C; Högy B
    Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous immunoglobulin (Endobulin) clinical tolerance: prospective therapeutic follow-up of 142 adults and children].
    Pautard B; Hachulla E; Bagot d'Arc M; Chantreuil L
    Rev Med Interne; 2003 Aug; 24(8):505-13. PubMed ID: 12888171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution of warts in association with subcutaneous immunoglobulin in immune deficiency.
    Lin JH; Wang KY; Kraft S; Roberts RL
    Pediatr Dermatol; 2009; 26(2):155-8. PubMed ID: 19419461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polyvalent immunoglobulins in prevention of viral infections in children with neoplastic diseases treated with immunosuppressive therapy].
    Graf N; Hille A; Jost W; Müller J
    Padiatr Padol; 1991; 26(4):187-91. PubMed ID: 1749627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HIV antibodies in patients receiving intravenous immunoglobulin.
    Bloom RD; Triglia D; Asser S
    Ann Allergy; 1988 Jul; 61(1):30-4. PubMed ID: 3133965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of selective antibody deficiency with IVIG resulting in decreased frequency of streptococcal infection and improvement of guttate psoriasis.
    Dhandha MM; Siegfried EC; Knutsen AP
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency.
    Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of severe acute disseminated encephalomyelitis with intravenous immunoglobulin].
    Andersen JB; Paerregaard A; Herning GM; Pedersen SA
    Ugeskr Laeger; 2000 May; 162(22):3197-9. PubMed ID: 10850212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.